Observational studyAmerican journal of hematology2022

SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies.

Evangelos Terpos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.